UFF
LH icon

USA Financial Formulas’s Labcorp LH Stock Holding History

USA Financial Formulas’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$800 – 482
2026
Q1 		$800 Hold
3
– – ﹤0.01% 349
2025
Q4 		$753 Sell
3
-2,676
-100% -$711K ﹤0.01% 333
2025
Q3 		$769K Buy
2,679
+59
+2% +$15.8K 0.14% 58
2025
Q2 		$688K Sell
2,620
-459
-15% -$112K 0.12% 78
2025
Q1 		$717K Buy
+3,079
New +$747K 0.12% 74
2022
Q1 		– Sell
-2
Closed -$1K – 432
2021
Q4 		$1K Sell
2
-4,605
-100% -$1.14M ﹤0.01% 331
2021
Q3 		$1.11M Sell
4,607
-786
-15% -$198K 0.99% 29
2021
Q2 		$1.28M Buy
+5,393
New +$1.23M 1.07% 12
2020
Q2 		– Sell
-8,802
Closed -$956K – 286
2020
Q1 		$956K Buy
+8,802
New +$1.27M 0.61% 60

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

USA Financial Formulas's LH Position: Q2 2026 in Review

USA Financial Formulas sold out of Labcorp (LH) in Q2 2026, closing a stake of 3 shares — an estimated $800 sold.

USA Financial Formulas first reported a position in LH in Q1 2020 and held it in 9 quarters. The position peaked at $1.28M in Q2 2021. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • USA Financial Formulas reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 3 Labcorp shares in Q2 2026, an estimated $800.
  • USA Financial Formulas first reported a position in Labcorp in Q1 2020 and held it in 9 quarters.
  • USA Financial Formulas's Labcorp position peaked at $1.28M in Q2 2021.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.